Cite
Exploring Two Dose Regimens of ITCA 650 to Switch from Stable Liraglutide Therapy in Type 2 Diabetes (T2D)
MLA
Prakash Prabhakar, et al. “Exploring Two Dose Regimens of ITCA 650 to Switch from Stable Liraglutide Therapy in Type 2 Diabetes (T2D).” Diabetes, vol. 67, July 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1008c2d44cce30acad183c89f3fd22ea&authtype=sso&custid=ns315887.
APA
Prakash Prabhakar, Neda Rasouli, Brian S. Schwartz, Samer Nakhle, Sydney L. Kruger, Michelle A. Baron, Julio Rosenstock, & Holly Huang. (2018). Exploring Two Dose Regimens of ITCA 650 to Switch from Stable Liraglutide Therapy in Type 2 Diabetes (T2D). Diabetes, 67.
Chicago
Prakash Prabhakar, Neda Rasouli, Brian S. Schwartz, Samer Nakhle, Sydney L. Kruger, Michelle A. Baron, Julio Rosenstock, and Holly Huang. 2018. “Exploring Two Dose Regimens of ITCA 650 to Switch from Stable Liraglutide Therapy in Type 2 Diabetes (T2D).” Diabetes 67 (July). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........1008c2d44cce30acad183c89f3fd22ea&authtype=sso&custid=ns315887.